MIAMI, June 24, 2025 (GLOBE NEWSWIRE) -- NextNRG, Inc. (Nasdaq: NXXT), a pioneer in AI-driven energy innovation transforming how energy is produced, managed, and delivered through its Next Utility Operating System®, smart microgrids, wireless EV charging, and mobile fuel delivery, today announced preliminary unaudited financial results for May 2025. May 2025 Highlights: "We're proud to report another month of strong revenue growth," said Michael D. Farkas, Executive Chairman and CEO of NextNRG. "This marks ...

HANGZHOU, China and LONDON, June 24, 2025 (GLOBE NEWSWIRE) -- MindRank, a clinical stage artificial intelligence (AI)-empowered drug discovery company, today announced positive topline results from a Phase 2b clinical trial of its proprietary AI-designed oral GLP-1 receptor agonist (GLP-1RA), MDR-001, in adults with obesity or overweight in China. Dr. Zhangming Niu, Founder and CEO of MindRank, commented: "The outstanding Phase 2b data validate the power of our AI-driven drug discovery engine and our intern ...

文章核心观点 美国教育部恢复违约联邦学生贷款借款人的催收活动后，逾期90天以上的学生贷款借款人数量持续攀升，大量借款人面临违约风险，但3 - 4月增幅较小或接近峰值，不同信用风险层级的借款人都可能面临违约问题，提醒贷款机构关注借款人风险 [1][5][9] 学生贷款逾期情况 - 截至2025年4月，31.0%有还款义务的联邦学生贷款借款人逾期90天以上，较2月的20.5%大幅增加，接近2020年2月疫情前11.7%的三倍 [2] - 2025年4月逾期90天以上的比例为有记录以来最高，但仅较3月的30.6%略有增加 [3] - 自2025年2月以来，逾期90天以上的联邦学生贷款借款人比例又增加了50% [4] 逾期借款人数量及违约预测 - 2025年4月逾期90天以上的借款人约580万，其中仅0.3%已违约 [6] - 预计约180万借款人可能在2025年7月违约，8月和9月分别还有100万和200万借款人可能违约 [7] 逾期对借款人信用的影响 - 新逾期的借款人信用评分平均下降60分（基于VantageScore® 4.0） [2] - 超过五分之一逾期90天以上的借款人此前处于优质或更高信用风险层级，逾期后不到五十分之一仍处于该层级，多数借款人信用风险层级下降 [8] 建议与措施 - 有违约风险的借款人应尽快联系贷款服务商，了解避免违约的方案，如收入驱动还款计划或贷款康复计划 [8] - 贷款机构应在定期投资组合审查中纳入学生贷款特定信息，以了解借款人的真实风险，可利用TruVision Premium Student Loan Attributes识别受影响的消费者 [9]

New York, NY, June 24, 2025 (GLOBE NEWSWIRE) -- Mixed Martial Arts Group Limited (NYSE American: MMA) ("MMA" or the "Company") a technology-driven company focused on transforming consumer engagement in martial arts and combat sports, today announced that its Founder and CEO, Nick Langton, and Chairman of the Board, Vaughn Taylor, have each converted $125,000 for a total of $250,000 in loans previously provided to the Company into common equity. MMA.INC (Mixed Martial Arts Group Limited) is revolutionizing t ...

Within the family program agenda, Aardvark's Chief Medical Officer, Manasi Jaiman, M.D., will join a panel of clinicians to discuss the details of the company's ongoing Phase 3 HERO study. Additional members of the company's medical and advocacy team invite the medical community and families attending to engage with attending team members at the company's booth to learn more about ARD-101, the HERO study and the company's commitment to the PWS community. SAN DIEGO, June 24, 2025 (GLOBE NEWSWIRE) -- Aardvark ...

Under the agreement, Cyclotek will produce and provide doses of Tb-labeled RAD 402 to support Radiopharm's upcoming Phase 1 clinical trial in prostate cancer in Australia. The Phase 1 trial is anticipated to start in the second half of 2025. RAD 402 preclinical data package complete; demonstrates safety and promising biodistribution profile Ethics approval and Phase 1 clinical trial start in prostate cancer anticipated in 2H 2025 SYDNEY and BUNDOORA, Australia, June 24, 2025 (GLOBE NEWSWIRE) -- Radiopharm T ...

TORONTO, June 24, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) ("PharmaTher" or the "Company"), a company focused on unlocking the pharmaceutical potential of ketamine, is pleased to announce that the United States Patent and Trademark Office (USPTO) has granted U.S. Patent No. 12,128,012, expiring May 14, 2041, for the use of ketamine in the treatment of Amyotrophic Lateral Sclerosis (ALS). This newly issued patent significantly strengthens the Company's intellectual propert ...

NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ("SELLAS" or the "Company"), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that the Company will be added to the Russell 3000 and Russell 2000 Indexes, effective after the U.S. market close on June 27, as part of the 2025 Russell indexes annual reconstitution. The Russell 3000 Index tracks the performance of the la ...

文章核心观点 - 东南亚领先社区电商和旅游平台Webuy Global Ltd.宣布任命Heng Wee Koon为独立董事兼薪酬委员会主席 强调其资历和战略价值 [1] 公司任命 - 公司宣布任命Heng Wee Koon为独立董事兼薪酬委员会主席 [1] 被任命人资历 - Heng Wee Koon拥有超25年并购、财务咨询和公司治理领导经验 [2] - 他现任Hyphens Pharma International Ltd.首席独立董事 该公司在其领导下获2024年新加坡企业奖最佳管理董事会金奖 [2] - 他曾是毕马威咨询合伙人 创立并购咨询公司Acelyr M&A和Acelyr Advisory [3] - 他拥有新加坡国立大学荣誉工商管理学士、南京大学工商管理硕士学位 是CFA持证人及新加坡董事学会高级认证董事 [4] 公司评价 - 公司CEO表示Heng Wee Koon在公司治理和战略咨询方面的专业知识对公司扩大规模很有价值 [4] - 他的广泛人脉、跨境交易经验及对并购和企业增长战略的深刻见解将推动新扩张机会 创造股东价值 支持公司长期可持续增长 [4] 公司简介 - 公司是技术驱动型企业 利用预测性AI、个性化推荐和社区参与提升团购模式 旅游业务通过专有AI旅游顾问提供定制行程和实时支持 [5] - 公司致力于提供高质量、实惠的产品和旅游服务 改善东南亚数百万人生活 [5]

文章核心观点 公司将召开电话会议讨论2025财年第二季度财务结果 [1] 会议信息 - 会议时间为2025年7月10日上午9点（东部时间） [1][2] - 免费拨入号码为877 - 709 - 8150 国际拨入号码为+1 201 - 689 - 8354 会议ID为13754369 [2] - 需提前10分钟拨打电话 接线员将登记姓名和组织 若连接困难可联系Gateway Group 电话为949 - 574 - 3860 [2] - 会议将直播 可在此处及公司网站投资者关系板块回放 [3] 公司介绍 - 公司是一家个人防御技术公司 专注于开发、制造和销售创新非致命个人安全解决方案 [1][4] - 公司生产Byrna SD个人安全设备 是一款先进的手持二氧化碳动力发射器 为消费、私人安保和执法市场提供非致命替代枪支的选择 [4] - 可访问公司电子商务商店购买产品 [4] 投资者联系方式 - 投资者联系人是Tom Colton和Alec Wilson [5] - 联系公司为Gateway Group, Inc. [5] - 联系电话为949 - 574 - 3860 邮箱为BYRN@gateway - grp.com [5]